病毒感染Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity.
期刊：The Journal of allergy and clinical immunology发表年份：2018作者：Caroline B K Mathiesen; Michael C Carlsson; Stephanie Brand; Svenning Rune Möller; Manja Idorn; Per Thor Straten; Anders E Pedersen; Sally Dabelsteen; Adnan Halim; Peter Adler Würtzen; Jens Brimnes; Henrik Ipsen; Bent L Petersen; Hans H Wandall